Dr Reddy’s Laboratories (DRL) plans to apply for emergency use approval (EUA) for the Russian Sputnik V from the Indian drug regulator in March and launch the vaccine around the
Dr Reddy's Laboratories likely to launch Sputnik V under EUA in March
The bridge trials on 1,600 participants in India was ongoing. The phase 2 trials are completed and the phase 3 is on.
 "Dr Reddy’s Laboratories likely to launch Sputnik V under EUA in March")
Premium
On the pricing front, the firm said it was discussing the Indian situation with RDIF.
First Published: Jan 30 2021 | 0:42 AM IST
Key stories on business-standard.com are available only to BS Premium subscribers.
Register to read more on Business-Standard.com
